Third, elevated levels of CCL2 and CCL8 were detected in the serum of elderly liver fibrosis patients carrying TET2 mutations, supporting the clinical relevance of a TET2–CCL2/8 regulatory axis in human disease, which provide a mechanistic basis for the potential clinical application of Bindarit. The gene discussed is TET2; the disease is Hepatic fibrosis.